Kither Biotech S.r.l
Kither Biotech is a pharma product company focused on the development of new drugs for the treatment of chronic inflammation and cancer.
- Stage Product In Development
- Industry Biotechnology
- Location Turin, Piedmont, Italy
- Currency EUR
- Founded November 2011
- Employees 2
Company Summary
Kither Biotech is a pharmaceutical product company, focused on the development of new drugs targeting PI3K enzymes involved in inflammation and cancer. Kither is committed to develop new molecules blocking PI3K for the treatment of chronic obstructive pulmonary disease, psoriasis and breast cancer. With these drugs, Kither intends to explore options for commercial exploitation, possibly through licensing agreements with pharmaceutical companies.
Team
-
Alberto BardelliFounder
Prof. at the University of Torino, Researcher and
co-founder of Horizon Discovery, a successful British biotech company -
Emilio HirschFounder
Prof. at the University of Torino, with high experience in studying the role of PI3K enzymes in chronic inflammation and cancer
-
Marco Kevin MalisaniFounder/CEO
Business executive with extensive experience in funding and managing start-up companies in Italy and Great Britain
-
Gian Cesare TronFounder
Prof. at the University of Piemonte Orientale, chemist with experience in multicomponent reactions drug synthesis
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.